| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.009 |